X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Despite Global Issues, Indian Pharma Exports Remain Strong

Content Team by Content Team
6th May 2022
in News
Indian Pharmaceutical Industry In 2021 And The Road Ahead

The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in 2021-22, with a phenomenal increase of about $10 billion in just eight years. Since 2013-14, the country’s pharmaceutical sector has grown by 103%, from Rs. 90,415 crore in 2013-14 to Rs. 1,83,422 crore in 2021-22. In the midst of COVID’s despair in 2020–21, the industry saw a dramatic increase in exports, reaching $24.4 billion, an 18% year-on-year rise.

Extreme export growth was realised in 2020–21 despite periodic lockouts, global supply chain disruptions, and a depressed manufacturing base. The country’s pharmaceutical arena was instrumental in the fight against the COVID-19 outbreak, demonstrating to the rest of the world that they happen to be a trustworthy and dependable companion when it comes to handling global health crises. As per a press release from India’s ministry of commerce and industry, the country has provided 115 million vaccine doses to over 97 countries.

India has struck a partnership agreement with the United Arab Emirates and Australia, which will allow Indian pharmaceutical products easier access to these markets.

Under the leadership of Prime Minister Shri Narendra Modi, India has been functioning as the “pharmacy of the world,” stated Piyush Goyal, Union Minister of Commerce and Industry, in a tweet. When compared to 2013-14, India’s rising drug and pharmaceutical shipments will more than double in 2021-22.

Building on the stellar showing of the preceding FY21, Indian pharmaceutical exports are expected to grow in 2021–22. Despite global trade disturbances and a reduction in demand for COVID-related drugs, pharma exports in 2021–22 grew at a favourable rate. With a surplus of $15175.81 million, India’s trade balance remains optimistic, according to a news release from the Ministry of Commerce and Industry.

With 60% of the world’s vaccines and 20% of generic medications coming from India, Indian pharmaceutical businesses have established a global imprint, owing to their price competitiveness and high quality.

Pharmaceuticals and drugs account for 5.92 percent of the global exports. Formulations and biologicals continue to make up the bulk of overall exports, which is 73.31%, followed by bulk medicines and drug intermediates pegged at $4437.64 million. The United States, the United Kingdom, South Africa, Russia, as well as Nigeria are India’s top five pharmaceutical export destinations. India is the world’s third-largest producer in terms of volume and fourteenth-largest producer in terms of value. The pharma gamut in India is currently valued at around $50 billion. Around 55% of its pharmaceutical exports are destined for highly controlled markets. The prescription landscape in the United States and Europe is dominated by Indian pharmaceutical companies. Outside of the United States, India has the most FDA-approved plants.

Previous Post

Newer Omicron Types Initiate Their Own Coronavirus Waves

Next Post

FDA Expects COVID Vaccines To Become An Annual Occurrence

Related Posts

SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Next Post
Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine

FDA Expects COVID Vaccines To Become An Annual Occurrence

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In